Bio-View Ltd (TLV:BIOV)

Market Cap	33.91M
Revenue (ttm)	25.66M
Net Income (ttm)	-3.15M
Shares Out	127.01M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,175
Average Volume	91,723
Open	26.70
Previous Close	26.70
Day's Range	26.70 - 26.70
52-Week Range	21.90 - 36.90
Beta	0.34
RSI	35.26
Earnings Date	Mar 26, 2025

About Bio-View

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies var...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 33
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BIOV